5 results on '"Motta, Santo"'
Search Results
2. Moving forward through the in silico modeling of tuberculosis: a further step with UISS-TB
- Author
-
Russo, Giulia, Sgroi, Giuseppe, Parasiliti Palumbo, Giuseppe Alessandro, Pennisi, Marzio, Juarez, Miguel A., Cardona, Pere-Joan, Motta, Santo, Walker, Kenneth B., Fichera, Epifanio, Viceconti, Marco, and Pappalardo, Francesco
- Published
- 2020
- Full Text
- View/download PDF
3. A methodological approach for using high-level Petri Nets to model the immune system response.
- Author
-
Pennisi, Marzio, Cavalieri, Salvatore, Motta, Santo, and Pappalardo, Francesco
- Subjects
IMMUNE system ,PATHOGENIC bacteria ,PETRI nets ,GLYCOPROTEINS ,HEMAGGLUTININ ,VIROLOGY - Abstract
Background: Mathematical and computational models showed to be a very important support tool for the comprehension of the immune system response against pathogens. Models and simulations allowed to study the immune system behavior, to test biological hypotheses about diseases and infection dynamics and to improve and optimize novel and existing drugs and vaccines. Continuous models, mainly based on differential equations, usually allow to qualitatively study the system but lack in description; conversely discrete models, such as agent based models and cellular automata, permit to describe in detail entities properties at the cost of losing most qualitative analyses. Petri Nets (PN) are a graphical modeling tool developed to model concurrency and synchronization in distributed systems. Their use has become increasingly marked also thanks to the introduction in the years of many features and extensions which lead to the born of "high level" PN. Results: We propose a novel methodological approach that is based on high level PN and in particular on Colored Petri Nets (CPN), that can be used to model the immune system response at the cellular scale. To demonstrate the potentiality of the approach we provide a simple model of the humoral immune system response that is able of reproducing some of the most complex well-known features of the adaptive response like memory and specificity features. Conclusions: The methodology we present has advantages of both the two classical approaches based on continuous and discrete models, since it allows to gain good level of granularity in the description of cells behavior without losing the possibility of having a qualitative analysis. Furthermore, the presented methodology based on CPN allows the adoption of the same graphical modeling technique well known to life scientists that use PN for the modeling of signaling pathways. Finally, such an approach may open the floodgates to the realization of multi scale models that integrate both signaling pathways (intra cellular) models and cellular (population) models built upon the same technique and software. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
4. Modeling the competition between lung metastases and the immune system using agents.
- Author
-
Pennisi, Marzio, Pappalardo, Francesco, Palladini, Ariannna, Nicoletti, Giordano, Nanni, Patrizia, Lollini, Pier-Luigi, and Motta, Santo
- Subjects
METASTASIS ,LUNG diseases ,IMMUNE system ,VACCINES ,TRANSGENIC mice - Abstract
Background: The Triplex cell vaccine is a cancer cellular vaccine that can prevent almost completely the mammary tumor onset in HER-2/neu transgenic mice. In a translational perspective, the activity of the Triplex vaccine was also investigated against lung metastases showing that the vaccine is an effective treatment also for the cure of metastases. A future human application of the Triplex vaccine should take into account several aspects of biological behavior of the involved entities to improve the efficacy of therapeutic treatment and to try to predict, for example, the outcomes of longer experiments in order to move faster towards clinical phase I trials. To help to address this problem, MetastaSim, a hybrid Agent Based -- ODE model for the simulation of the vaccine-elicited immune system response against lung metastases in mice is presented. The model is used as in silico wet-lab. As a first application MetastaSim is used to find protocols capable of maximizing the total number of prevented metastases, minimizing the number of vaccine administrations. Results: The model shows that it is possible to obtain "in silico" a 45% reduction in the number of vaccinations. The analysis of the results further suggests that any optimal protocol for preventing lung metastases formation should be composed by an initial massive vaccine dosage followed by few vaccine recalls. Conclusions: Such a reduction may represent an important result from the point of view of translational medicine to humans, since a downsizing of the number of vaccinations is usually advisable in order to minimize undesirable effects. The suggested vaccination strategy also represents a notable outcome. Even if this strategy is commonly used for many infectious diseases such as tetanus and hepatitis-B, it can be in fact considered as a relevant result in the field of cancer-vaccines immunotherapy. These results can be then used and verified in future "in vivo" experiments, and their outcome can be used to further improve and refine the model. [ABSTRACT FROM AUTHOR]
- Published
- 2010
5. Discovery of cancer vaccination protocols with a genetic algorithm driving an agent based simulator.
- Author
-
Lollini PL, Motta S, and Pappalardo F
- Subjects
- Animals, Apoptosis drug effects, Apoptosis immunology, Cell Survival drug effects, Cell Survival immunology, Computer Simulation, Expert Systems, Mammary Neoplasms, Experimental pathology, Mice, Models, Genetic, T-Lymphocytes drug effects, T-Lymphocytes immunology, Treatment Outcome, Algorithms, Cancer Vaccines administration & dosage, Drug Therapy, Computer-Assisted methods, Immunization Schedule, Mammary Neoplasms, Experimental immunology, Mammary Neoplasms, Experimental prevention & control, Models, Immunological
- Abstract
Background: Immunological prevention of cancer has been obtained in HER-2/neu transgenic mice using a vaccine that combines 3 different immune stimuli (Triplex vaccine) that is repeatedly administered for the entire lifespan of the host (Chronic protocol). Biological experiments leave open the question of whether the Chronic protocol is indeed the minimal vaccination schedule affording 100% protection, or whether shorter protocols could be applied that would result in the same efficacy. A biological solution would require an enormous number of experiments, each lasting at least one year. Therefore we approached this problem by developing a simulator (SimTriplex) which describes the immune response activated by Triplex vaccine. This simulator, tested against in vivo experiments on HER-2/neu mice, reproduces all the vaccination protocols used in the in vivo experiments. The simulator should describe any vaccination protocol within the tested range. A possible solution to the former open question using a minimal search strategy based on a genetic algorithm is presented. This is the first step toward a more general approach of biological or clinical constraints for the search of an effective vaccination schedule., Results: The results suggest that the Chronic protocol included a good number of redundant vaccine administrations, and that maximal protection could still be obtained with a number of vaccinations approximately 40% less than with the Chronic protocol., Conclusion: This approach may have important connotations with regard to translation of cancer immunopreventive approaches to human situations, in which it is desirable to minimize the number of vaccinations. We are currently setting up experiments in mice to test whether the actual effectiveness of the vaccination protocol agrees with the genetic algorithm.
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.